Treatment effects maintained over five years in Lemtrada...
Posted: Thu Oct 08, 2015 2:45 am
Treatment effects maintained over five years in Lemtrada patients
Genzyme, has announced new five-year investigational data from the extension study of Lemtrada for patients with relapsing remitting multiple sclerosis (RRMS)... Read More - http://www.ms-uk.org/MSnews
Genzyme, has announced new five-year investigational data from the extension study of Lemtrada for patients with relapsing remitting multiple sclerosis (RRMS)... Read More - http://www.ms-uk.org/MSnews